Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$110.31 - $140.45 $4,191 - $5,337
38 Added 2.06%
1,881 $213,000
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $9,251 - $11,348
81 Added 4.6%
1,843 $255,000
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $95,645 - $157,310
-1,267 Reduced 41.83%
1,762 $218,000
Q3 2023

Nov 03, 2023

SELL
$86.06 - $137.93 $17,642 - $28,275
-205 Reduced 6.34%
3,029 $282,000
Q2 2023

Aug 11, 2023

SELL
$112.47 - $130.98 $46,450 - $54,094
-413 Reduced 11.32%
3,234 $415,000
Q1 2023

May 08, 2023

BUY
$104.0 - $122.92 $20,384 - $24,092
196 Added 5.68%
3,647 $423,000
Q4 2022

Jan 25, 2023

SELL
$84.98 - $122.67 $89,398 - $129,048
-1,052 Reduced 23.36%
3,451 $0
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $42,221 - $52,081
553 Added 14.0%
4,503 $362,000
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $208,321 - $407,174
3,064 Added 345.82%
3,950 $294,000
Q1 2022

May 13, 2022

BUY
$94.08 - $130.2 $4,986 - $6,900
53 Added 6.36%
886 $453,000
Q4 2021

Feb 09, 2022

BUY
$129.87 - $162.82 $4,155 - $5,210
32 Added 4.0%
833 $447,000
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $7,362 - $9,879
69 Added 9.43%
801 $499,000
Q2 2021

Jul 29, 2021

BUY
$80.99 - $107.93 $59,284 - $79,004
732 New
732 $313,000
Q1 2019

Apr 09, 2019

SELL
$28.07 - $38.18 $1,768 - $2,405
-63 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$26.99 - $37.37 $1,700 - $2,354
63 New
63 $7,000
Q3 2018

Oct 09, 2018

SELL
$23.35 - $36.72 $1,027 - $1,615
-44 Closed
0 $0
Q4 2017

Feb 16, 2018

BUY
$11.12 - $15.38 $489 - $676
44
44 $3,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.